Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
249 Leser
Artikel bewerten:
(1)

Bedfont Scientific Ltd. teams up with GI Cognition to launch Hydrogen and Methane Breath Testing 'Home Kits' to help improve Gastric Health remotely

Bedfont presents its new Hydrogen and Methane Breath Testing Home Kits in association with GI Cognition

MAIDSTONE, England, June 1, 2021 /PRNewswire/ -- With the pandemic of COVID-19 bringing a halt to most medical tests and procedures, it has highlighted a need to safely, easily, and remotely find a way for health services to continue treating their patients, especially in the field of Gastroenterology. Global breath analysis manufacturer, Bedfont Scientific Ltd., has teamed up with GI Cognition to do just that in launching its new Hydrogen and Methane Breath Testing (HMBT) 'Home Kits' to help improve Gastric Health remotely.

Known for their innovative medical devices, Bedfont brings their 32 years of Hydrogen and Methane monitoring knowledge and has created a simple and patient-friendly HBMT Home Kit, which allows patients to be tested remotely for many digestive issues, including food intolerances, IBS, and SIBO. The Home Kits will be distributed by GI Cognition; a UK network of qualified GI physiologists, providing a unique and innovative mobile gastrointestinal physiology service.

According to NICE, IBS prevalence in the UK population is estimated to be between 10% and 20%1 and SIBO affects 1 in 7 according to the London Gastroenterology Centre2. GI Cognition was first established to ease the pressure on UK hospitals who deal with long waiting times and convoluted processes for their gastroenterology outpatients. By teaming up with Bedfont to offer HBMT Home Kits, they can not only accomplish this, but also help Bedfont to raise awareness of gastrointestinal health and give the patient more knowledge and control of their own gastric health.

Dr. Jafar Jafari, Head Of Upper GI Physiology Service at Guys and St Thomas Hospital, and Executive Director at GI Cognition, explains, "Hydrogen and methane breath testing is an invaluable tool in helping to detect gastrointestinal disorders, but unfortunately there are not enough qualified GI physiologists in the UK to meet the growing demand from patients and hospitals, causing a shortage of upper GI testing services, including HBMT; GI cognition was established to remedy this. We are excited to be working with Bedfont on HBMT Home Kits to help bridge the gap."

Jason Smith, Managing Director at Bedfont, adds, "For some time there has been a need to help reduce the pressure on gastroenterology health services and with the pandemic, we decided to focus on developing the Home Kits sooner. Through remote breath analysis, more patients can be seen, without having to leave the comfort of their homes, meaning they can receive great care and stop living in discomfort by better understanding and taking control of their digestive health."

References:

  1. Introduction | Irritable bowel syndrome in adults: diagnosis and management | Guidance | NICE [Internet]. Nice.org.uk. 2021 [cited 20 May 2008]. Available from: https://www.nice.org.uk/guidance/cg61/chapter/introduction#:~:text=IBS%20most%20often%20affects%20people,of%20IBS%20in%20older%20people.
  2. SIBO (Small Intestinal Bacterial Overgrowth) - Treating, Testing & Preventing [Internet]. London Gastroenterology Centre. 2018 [cited 20 May 2021]. Available from: https://www.gastrolondon.co.uk/overview-of-diagnosis-and-management-of-small-intestinal-bacterial-overgrowth/

About Bedfont

Established in 1976, Bedfont Scientific Limited is a second generation family company that has specialised in the design and manufacture of exhaled breath and gas monitoring instruments for medical application, globally, for over 40 years. Bedfont is revered as a pioneer in the breath analysis market with their products now available in over 76 countries across the world thanks to their unprecedented network of appointed distributors. Their aim is to continue innovating and improving health worldwide.

Products include:

  • Smokerlyzer:
    Range of carbon monoxide monitors for use in smoking cessation programmes
  • NObreath :
    Fractional exhaled Nitric Oxide (FeNO) device to provide accurate analysis of airway inflammation
  • Gastrolyzer :
    Range of breath hydrogen and methane monitors to aid in the detection of gastrointestinal disorder.
  • ToxCO :
    Carbon monoxide monitor used by the emergency services to detect carbon monoxide poisoning
  • Medi-Gas Check:
    Range of fixed and portable gas detection monitors, used to verify and validate the quantity and quality of medical gas administered to patients

www.bedfont.com

© 2021 PR Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.